A new recombinant factor VIII: from genetics to clinical use
Drug Des Devel Ther
.
2015 Jul 23:9:3817-9.
doi: 10.2147/DDDT.S85608.
eCollection 2015.
Authors
Christoph Kannicht
1
,
Guido Kohla
1
,
Maya Tiemeyer
2
,
Olaf Walter
3
,
Helena Sandberg
4
Affiliations
1
Octapharma Biopharmaceuticals GmbH, Molecular Biochemistry, Berlin, Germany.
2
Octapharma Biopharmaceuticals GmbH, Heidelberg, Germany.
3
Octapharma AG, Lachen, Switzerland.
4
CoaBio AB, Bromma, Sweden.
PMID:
26229443
PMCID:
PMC4517516
DOI:
10.2147/DDDT.S85608
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Factor VIII / genetics*
Factor VIII / therapeutic use*
Hemophilia A / therapy*
Humans
Substances
Factor VIII